Atovaquone/Proguanil (Malarone) for Malaria
A fixed-dose combination of atovaquone and proguanil hydrochloride has been approved by the FDA for oral prophylaxis and treatment of malaria due to Plasmodium falciparum, including choloroquine-resistant strains....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Atovaquone/Proguanil (Malarone) for Malaria
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1093
Article Code: 1093a
Date: November 27, 2000
Volume: 42
Pages: 109-111
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1093
Article Code: 1093a
Date: November 27, 2000
Volume: 42
Pages: 109-111
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)